Role of inflammatory markers in the pathogenesis and outcome of atrial fibrillation different clinical forms
https://doi.org/10.38109/2225-1685-2011-1-28-31
Abstract
Under our observation were undergoing 141 patients with non-rheumatic AF. The study included patients with paroxysmal, persistent and permanent forms of AF and as a control group - patients without AF. The similar analysis of the obtained results showed that patients with paroxysmal and persistent AF types have a statistically significant increase in levels of CRP and IL-6 compared to pateints with chronic form and the control group. Therefore, we can suggest that the increased concentration of inflammatory markers such as CRP and IL-6 may serve as a predictor of the appearance of paroxysmal form or recurrence of AF.
About the Authors
K. G. Adamyan
Институт кардиологии им Л. А. Оганесяна; Национальный институт здравоохранения им. С. Х. Авдалбекяна г. Ереван, Армения
Armenia
Armenia
L. G. Azarapetyan
Национальный институт здравоохранения им. С. Х. Авдалбекяна, г. Ереван, Республика Армения
Armenia
Armenia
References
1. Кушаковский М.С. Аритмии сердца. Руководство для врачей - СПб.: ИКФ «Фолиант»».- 2004, 672 с
2. Acevedo M., Corbalan R., Braun S. et al. C-reactive protein and atrial fibrillation: «Evidence for the presence of inflammation in the perpetuation of the arrhythmia» II Am J Cardiol., 2005
3. Avelis R. J. David O. M., Apperson-Hansen C. et al. Inflammation as a rise factor for atrial fibrillation II Circulation, 2003, Vol. 108, P. 3006-3010.
4. Boss Ch. J, Lip G. Y. H The role of inflammation in atrial fibrillation International J. of Clinicfl Practice, 2005,59 (8), 870-872
5. Cosgrave J,Foley J.,Bahadur K.et al.Inflammatory markers are not associated with outcomes following elective external cardioversion.Am J Cardiol.-2006.-Vol.110,3,-P373-377
6. Cheruku K.K. et al, Efficacy of nonsteroidal antiinflammatory medications for prevention of atrial fibrillation following coronary bypass graft surgery. Prev Cardiol 2004,7; 13-18
7. Dernellis J, Panaretou M. Effect of C-reactive protein reduction on paroxysmal atrial fibrillation Amer. Heart J, 2005, 12-14
8. Falk R. H. Atrial Fibrillation //The New England Journal of Medicine. - 2001.- Vol. 344, №14. - P 10671078.
9. Hernandez A. C-reactive protein and atrial fibrillation. An old marker looking tor new target. Rev.Esp. Cardiol. 2006,59,94-98
10. Loricchio M.L., Cianfrocca C., Pasceri V. et al. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion Am.J.Cardiol. 2007,99, 1421-1424
11. ACTAHAESC 2006 Guideline for the management of patients with atrial fibrillation - executive summary Europ. Heart J, 2006, vol. 27, 16 1979-2030
Review
For citations:
Adamyan K.G., Azarapetyan L.G. Role of inflammatory markers in the pathogenesis and outcome of atrial fibrillation different clinical forms. Eurasian heart journal. 2011;(1):28-31. (In Russ.) https://doi.org/10.38109/2225-1685-2011-1-28-31
Views:
264
Email this article 
